Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ibn Alhaytham HospitalAMM:IBNH 33 EV-to-EBITDA is 12.06 as of Jul. 20, 2026, which is 49% above its 10-year median of 8.12. GuruFocus rates AMM:IBNH with a GF Score™ of 33/100 and a GF Value™ of JOD0.84. The stock has 9 warning signs investors should review. Among 506 Healthcare Providers & Services companies, Ibn Alhaytham Hospital ranks worse than 54.55% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ibn Alhaytham Hospital's enterprise value is JOD27.96 Mil.
Ibn Alhaytham Hospital's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was JOD2.32 Mil. Therefore, Ibn Alhaytham Hospital's EV-to-EBITDA for today is 12.06.
The historical rank and industry rank for Ibn Alhaytham Hospital's EV-to-EBITDA or its related term are showing as below:
AMM:IBNH'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -54.73 Med: 8.12 Max: 34.86
Current: 12.06
During the past 13 years, the highest EV-to-EBITDA of Ibn Alhaytham Hospital was 34.86. The lowest was -54.73. And the median was 8.12.
AMM:IBNH's EV-to-EBITDA is ranked worse than 54.55% of 506
companies
in the Healthcare Providers & Services industry
Industry Median: 11.1
vs AMM:IBNH: 12.06
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Ibn Alhaytham Hospital (AMM:IBNH) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ibn Alhaytham Hospital's PE Ratio (TTM) for today is calculated as:
Ibn Alhaytham Hospital's share price for today is JOD0.86.
Ibn Alhaytham Hospital's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was JOD0.009.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AMM:IBNH vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Ibn Alhaytham Hospital's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ibn Alhaytham Hospital EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ibn Alhaytham Hospital's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Ibn Alhaytham Hospital's EV-to-EBITDA falls into.
Ibn Alhaytham Hospital's current Enterprise Value is JOD27.96 Mil.
Ibn Alhaytham Hospital's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was JOD2.32 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ibn Alhaytham Hospital (AMM:IBNH) has a EV-to-EBITDA of 12.06 as of Jul. 20, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Ibn Alhaytham Hospital. This is 49% above median its historical median of 8.12. According to the industry distribution chart, Ibn Alhaytham Hospital ranks #276 out of 506 companies in the Healthcare Providers & Services industry, placing it in the top 54.5%.
Is Ibn Alhaytham Hospital's EV-to-EBITDA too high?
Ibn Alhaytham Hospital's current EV-to-EBITDA of 12.06 is 49% above median its 10-year median of 8.12. The Healthcare Providers & Services industry median EV-to-EBITDA is 11.10. Ibn Alhaytham Hospital's value of 12.06 is 8.6% above this industry median. Based on the distribution chart, Ibn Alhaytham Hospital ranks #276 out of 506 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Ibn Alhaytham Hospital has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Ibn Alhaytham Hospital's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ibn Alhaytham Hospital ranks #276 out of 506 companies for EV-to-EBITDA. This places Ibn Alhaytham Hospital in the lower half of its industry. The industry median EV-to-EBITDA is 11.10. Ibn Alhaytham Hospital's value of 12.06 is 8.6% above this benchmark. While the company's 10-year median is 8.12 vs. the industry median of 11.10, Ibn Alhaytham Hospital has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.10, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ibn Alhaytham Hospital's current EV-to-EBITDA of 12.06 is 8.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Ibn Alhaytham Hospital. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ibn Alhaytham Hospital's current EV-to-EBITDA is 12.06, which is 49% above median its own 10-year median of 8.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ibn Alhaytham Hospital stock overvalued right now?
Ibn Alhaytham Hospital (AMM:IBNH) has a current EV-to-EBITDA of 12.06. The stock's GF Value™ is JOD0.84, compared to a current price of JOD0.86 — trading 2.4% above its estimated fair value. The current EV-to-EBITDA is 12.06, which is 49% above median its 10-year median of 8.12 and 8.6% above the Healthcare Providers & Services industry median of 11.10. Ibn Alhaytham Hospital's overall GF Score™ is 33/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Ibn Alhaytham Hospital (AMM:IBNH), the current EV-to-EBITDA is 12.06 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ibn Alhaytham Hospital (AMM:IBNH) Overvalued in 2026?
Based on GuruFocus' analysis, Ibn Alhaytham Hospital stock appears to be overvalued.
The current stock price of JOD0.86 is trading 2.4% above its estimated GF Value™ of JOD0.84.
Key valuation signals for AMM:IBNH:
EV-to-EBITDA: 12.06 (49% above median its 10-year median of 8.12)
GF Value™: JOD0.84 vs. price of JOD0.86 (2.4% above fair value)
Industry Position: 8.6% above the Healthcare Providers & Services median (#276 of 506)
No single metric tells the full story. See the AMM:IBNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ibn Alhaytham Hospital operates as a hospital in Jordan. The Company's main objectives is to found and establish a hospital for general casses And especially ophthalmology, Otorhinolaryngology, Medicine and Neurosurgery and to Import a necessary medical equipment and supplies. The company operates in segments, which comprise of Medical & investments and others.
33GF Score
Get the complete analysis for AMM:IBNH
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:IBNH has been successfully added to your 
